Skip to main content

September 2021 / VIDEO

The Three Drivers of Innovation in Biotech Stocks

Innovation in the biotech industry is creating investment opportunities in stocks that will help shape the future of medicine

 

Three drivers of innovation in the biotech industry—technological advancements in research tools, an increasing supply of investment capital, and a maturing contract research and development field—are creating investment opportunities that will help shape the future of medicine.

 

 

IMPORTANT INFORMATION

This material is being furnished for general informational and/or marketing purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, nor is it intended to serve as the primary basis for an investment decision. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.

The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.

Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources' accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date noted on the material and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.

The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request.  

It is not intended for distribution to retail investors in any jurisdiction.

Previous Article

September 2021 / MARKETS & ECONOMY

UK Turns to Bold Post-Brexit Reforms to Boost Economy
Next Article

September 2021 / INVESTMENT INSIGHTS

Innovations in Sustainability Are Reshaping the Future of Plastic
202108-1761300

September 2021 / INVESTMENT INSIGHTS

Why There’s More to China than Just Big Tech

Why There’s More to China than Just Big Tech

Why There’s More to China than Just Big Tech

Mainstream indices are a poor reference point for investors in China

By Irmak Surenkok & Robert Secker

By Irmak Surenkok & Robert Secker

September 2021 / MARKETS & ECONOMY

Germany’s New Government Is Likely to Rewrite Economic Policy

Germany’s New Government Is Likely to Rewrite Economic Policy

Germany’s New Government Is Likely to Rewrite...

There will be a focus on green fiscal policy and redistribution

By Tomasz Wieladek

Tomasz Wieladek T.Rowe Price International Economist

You are now leaving the T. Rowe Price website

T. Rowe Price is not responsible for the content of third party websites, including any performance data contained within them. Past performance cannot guarantee future results.